---
title: Barriers to the Implementation of Complete Insulin Order Sets
nct_id: NCT00813280
overall_status: COMPLETED
sponsor: HealthPartners Institute
study_type: OBSERVATIONAL
primary_condition: Hyperglycemia
countries: United States
canonical_url: "https://parkinsonspathways.com/agent/trials/NCT00813280.md"
clinicaltrials_gov: "https://clinicaltrials.gov/study/NCT00813280"
ct_last_update_post_date: 2015-11-26
last_seen_at: "2026-05-12T06:12:49.685Z"
source: ClinicalTrials.gov (mirrored, no enrichment)
---
# Barriers to the Implementation of Complete Insulin Order Sets

**Official Title:** Barriers to the Implementation of Complete Insulin Order Sets in the Management of Individuals With Hyperglycemia or Diabetes at Park Nicollet Methodist Hospital

**NCT ID:** [NCT00813280](https://clinicaltrials.gov/study/NCT00813280)

## Key Facts

- **Status:** COMPLETED
- **Study Type:** OBSERVATIONAL
- **Target Enrollment:** 200
- **Lead Sponsor:** HealthPartners Institute
- **Collaborators:** International Diabetes Center at Park Nicollet, Park Nicollet Foundation
- **Conditions:** Hyperglycemia
- **Start Date:** 2008-06
- **Completion Date:** 2008-12
- **CT.gov Last Update:** 2015-11-26

## Brief Summary

The major purpose of this Quality Improvement project is to begin to address the issues surrounding glycemic control in the hospital setting by collecting accurate, reliable and verifiable data on the occurrence of hyperglycemia (BG \>300 mg/dL), and whether or not CIO is used (immediately before and 72 hours after the BG \>300 mg/dl).

## Eligibility

- **Minimum age:** 18 Years
- **Sex:** ALL
- **Healthy Volunteers:** No

```
Inclusion Criteria:

* Park Nicollet Methodist Hospital patient
* recorded BG \> 300 mg/dL during the study data collection period
* admitted to general floor hospital units

Exclusion Criteria:

* birth center
* intensive care units
* eating disorder unit
* pediatric patients \< 18 years of age
* patients receiving insulin infusions
```

## Arms

- **hyperglycemia** — hospitalized patients with BG \>300 ml/dL

## Primary Outcomes

- **glucose levels** _(time frame: 72 hours)_

## Secondary Outcomes

- **type of insulin treatment** _(time frame: 72 hours)_

## Locations (1)

- Park Nicollet Methodist Hospital, Minneapolis, Minnesota, United States

## Recent Field Changes (last 30 days)

- `status.lastUpdatePostDate` — added _(2026-05-12)_
- `design.enrollmentCount` — added _(2026-05-12)_
- `status.overallStatus` — added _(2026-05-12)_
- `status.primaryCompletionDate` — added _(2026-05-12)_
- `status.completionDate` — added _(2026-05-12)_
- `eligibility.criteria` — added _(2026-05-12)_
- `eligibility.minAge` — added _(2026-05-12)_
- `eligibility.sex` — added _(2026-05-12)_
- `outcomes.primary` — added _(2026-05-12)_
- `outcomes.secondary` — added _(2026-05-12)_
- `armsInterventions.arms` — added _(2026-05-12)_
- `sponsor.lead` — added _(2026-05-12)_
- `sponsor.collaborators` — added _(2026-05-12)_
- `results.hasResults` — added _(2026-05-12)_
- `locations.park nicollet methodist hospital|minneapolis|minnesota|united states` — added _(2026-05-12)_

---

*Canonical: https://parkinsonspathways.com/agent/trials/NCT00813280.md*  
*Source data (authoritative): https://clinicaltrials.gov/study/NCT00813280*  
*This page is a raw mirror with no AI summary, no editorial enrichment, and no Parkinson's-specific filtering.*